Westlake Chemical Partners LP
WLKP Basic Materials Chemicals
Westlake Chemical Partners LP’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 2.71% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 2.44%, free cash flow grew 866.7% and total debt was flat, each against the same quarter a year earlier. Dividend growth for ten consecutive years.
Follow WLKP
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
88.90 | 27.01 | 19.74 | 19.92 | 17.15 | 17.06 | 64.78 | 58.62 | 58.32 | 44.27 |
Receivables |
139.06 | 198.48 | 222.64 | 215.53 | 242.29 | 254.86 | 175.99 | 162.71 | 178.11 | 96.06 |
Inventory |
3.93 | 5.59 | 4.39 | 2.48 | 3.47 | 8.90 | 4.72 | 4.43 | 4.06 | 2.77 |
Total current assets |
232.17 | 231.39 | 247.14 | 238.41 | 263.31 | 281.21 | 245.79 | 226.20 | 240.93 | 143.51 |
Property, Plant, Equpment (Net) |
1,222.24 | 1,196.25 | 1,148.27 | 1,103.00 | 1,050.68 | 1,043.54 | 990.21 | 943.84 | 903.59 | 886.01 |
Goodwill and Intangible Assets (Total) |
5.81 | 5.81 | 5.81 | 5.81 | 5.81 | 5.81 | 5.81 | 5.81 | 5.81 | 5.81 |
Total non-current assets |
1,323.06 | 1,283.89 | 1,214.98 | 1,155.05 | 1,093.18 | 1,199.49 | 1,126.19 | 1,090.64 | 1,047.03 | 1,113.03 |
Total Assets |
1,555.23 | 1,515.28 | 1,462.13 | 1,393.46 | 1,356.49 | 1,480.70 | 1,371.98 | 1,316.84 | 1,287.96 | 1,256.53 |
Accounts Payable |
22.06 | 24.54 | 32.52 | 21.34 | 20.99 | 45.90 | 49.40 | 31.36 | 38.45 | 29.10 |
Accrued Expenses |
15.72 | 15.70 | 16.25 | 17.51 | 18.77 | 60.90 | 17.54 | 24.98 | 16.92 | 22.20 |
Total current liabilities |
37.78 | 40.24 | 48.77 | 38.85 | 39.75 | 106.80 | 66.94 | 56.34 | 55.37 | 51.30 |
Long Term Debt (Total) |
594.63 | 473.96 | 477.61 | 399.67 | 399.67 | 399.67 | 399.67 | 399.67 | 399.67 | 399.67 |
Long Term Tax Liability (Deferred) |
1.74 | 2.22 | 1.66 | 1.65 | 1.54 | 1.53 | 1.66 | 1.63 | 1.55 | 1.55 |
Non-current Liabilities (Other) |
0.12 | 0.11 | — | 1.15 | 0.38 | — | — | 2.95 | 2.05 | 1.66 |
Total non-current liabilities |
596.49 | 476.29 | 479.27 | 402.47 | 401.60 | 401.20 | 401.33 | 404.26 | 403.27 | 402.88 |
Total liabilities |
634.27 | 516.53 | 528.04 | 441.32 | 441.35 | 508.00 | 468.27 | 460.59 | 458.64 | 454.18 |
Common Stock (Net) |
344.71 | 461.49 | 458.38 | 520.09 | 519.97 | 536.55 | 534.50 | 522.51 | 518.70 | 501.11 |
Shareholders Equity (Other) |
(242.43) | (241.96) | (242.57) | (242.57) | (242.57) | (242.57) | (242.57) | (242.57) | (242.57) | (242.57) |
Common Equity (Total) |
920.96 | 998.75 | 934.08 | 952.13 | 915.14 | 972.70 | 903.71 | 856.25 | 829.31 | 802.35 |
Shareholders Equity (Total) |
920.96 | 998.75 | 934.08 | 952.14 | 915.14 | 972.70 | 903.71 | 856.25 | 829.31 | 802.35 |
Shareholders Equity and Liabilities (Total) |
1,555.23 | 1,515.28 | 1,462.13 | 1,393.46 | 1,356.49 | 1,480.70 | 1,371.98 | 1,316.84 | 1,287.96 | 1,256.53 |
Shares (Common) |
27.06 | 32.24 | 32.25 | 35.19 | 35.20 | 35.21 | 35.22 | 35.23 | 35.24 | 35.25 |
Shareholders Equity (Tangible) |
915.15 | 992.94 | 928.27 | 946.32 | 909.32 | 966.88 | 897.89 | 850.44 | 823.50 | 796.54 |
Net Debt |
505.73 | 446.95 | 457.86 | 379.75 | 382.52 | 382.62 | 334.89 | 341.06 | 341.36 | 355.41 |
Total Debt |
594.63 | 473.96 | 477.61 | 399.67 | 399.67 | 399.67 | 399.67 | 399.67 | 399.67 | 399.67 |